Precision Oncology Market
Precision Oncology Market
The global precision oncology market is expected to reach an estimated USD 310.75 billion by 2034, growing from USD 120.9 billion in 2024 at a steady CAGR of 9.9% (2024 - 2034). This growth is driven by the rising prevalence of cancer and the increasing demand for personalized medicine.
Report ID: 10045
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 120.9 Bn
Forecast Year,
USD USD 310.75 Bn
CAGR, 2025 -
9.9%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Precision Oncology Market Size Analysis
Precision Oncology Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insulin | 28.18 | 29.99 | 32.24 | 33.97 | 36.89 | 38.48 | 42.20 | 43.59 | 48.28 | 49.37 | 55.24 |
| DPP- 4 Inhibitors | 14.09 | 15.11 | 15.88 | 17.37 | 17.90 | 19.97 | 20.17 | 22.96 | 22.72 | 26.39 | 25.60 |
| GLP-1 Receptor Agonists | 17.61 | 18.71 | 20.21 | 21.14 | 23.19 | 23.87 | 26.61 | 26.95 | 30.53 | 30.43 | 35.03 |
| SGLT2 Inhibitors | 10.57 | 11.35 | 11.87 | 13.09 | 13.33 | 15.10 | 14.97 | 17.41 | 16.80 | 20.08 | 18.86 |
Precision Oncology Market Size By Diabetes Type 2024 to 2034 (USD )
| Diabetes Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Type 1 | 17.61 | 18.71 | 20.21 | 21.14 | 23.19 | 23.87 | 26.61 | 26.95 | 30.53 | 30.43 | 35.03 |
| Type 2 | 52.83 | 56.44 | 59.99 | 64.43 | 68.11 | 73.55 | 77.34 | 83.96 | 87.81 | 95.84 | 99.70 |
Precision Oncology Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 35.22 | 37.54 | 40.18 | 42.66 | 45.83 | 48.46 | 52.28 | 55.06 | 59.64 | 62.56 | 68.03 |
| Subcutaneous | 31.70 | 33.93 | 35.86 | 38.88 | 40.56 | 44.55 | 45.88 | 51.04 | 51.89 | 58.48 | 58.69 |
| Intravenous | 3.52 | 3.69 | 4.16 | 4.03 | 4.91 | 4.41 | 5.79 | 4.80 | 6.81 | 5.22 | 8.00 |
Precision Oncology Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Online pharmacies | 10.57 | 11.21 | 12.17 | 12.62 | 14.00 | 14.20 | 16.12 | 15.97 | 18.55 | 17.97 | 21.34 |
| Hospital Pharmacies | 24.65 | 26.41 | 27.85 | 30.30 | 31.46 | 34.76 | 35.54 | 39.87 | 40.15 | 45.74 | 45.35 |
| Retail pharmacies | 35.22 | 37.54 | 40.18 | 42.66 | 45.83 | 48.46 | 52.28 | 55.06 | 59.64 | 62.56 | 68.03 |
Precision Oncology Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 28.18 | 30.04 | 32.14 | 34.13 | 36.65 | 38.79 | 41.80 | 44.08 | 47.68 | 50.10 | 54.37 |
| Europe | 19.72 | 21.10 | 22.33 | 24.16 | 25.28 | 27.65 | 28.63 | 31.65 | 32.41 | 36.23 | 36.70 |
| Asia-Pacific | 15.50 | 16.50 | 17.72 | 18.70 | 20.26 | 21.20 | 23.16 | 24.04 | 26.48 | 27.24 | 30.27 |
| Latin America | 3.52 | 3.81 | 3.91 | 4.44 | 4.34 | 5.18 | 4.81 | 6.04 | 5.32 | 7.03 | 5.89 |
| Middle East & Africa | 3.52 | 3.72 | 4.10 | 4.13 | 4.77 | 4.59 | 5.55 | 5.10 | 6.45 | 5.66 | 7.50 |
Precision Oncology Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
